WallStSmart

Dynex Capital Inc (DX)vsRithm Capital Corp. (RITM)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Rithm Capital Corp. generates 28567% more annual revenue ($4.86B vs $16.95M). RITM leads profitability with a 10.2% profit margin vs -293.5%. RITM trades at a lower P/E of 14.7x. RITM earns a higher WallStSmart Score of 65/100 (C+).

DX

Buy

55

out of 100

Grade: C-

Growth: 8.3Profit: 3.0Value: 5.7Quality: 2.5
Piotroski: 2/9Altman Z: -0.72

RITM

Buy

65

out of 100

Grade: C+

Growth: 8.7Profit: 6.0Value: 7.7Quality: 2.5
Piotroski: 2/9Altman Z: 0.40
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DX.

RITMUndervalued (+84.9%)

Margin of Safety

+84.9%

Fair Value

$70.99

Current Price

$9.00

$61.99 discount

UndervaluedFair: $70.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DX4 strengths · Avg: 9.5/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
234.8%10/10

Revenue surging 234.8% year-over-year

EPS GrowthGrowth
92.3%10/10

Earnings expanding 92.3% YoY

PEG RatioValuation
0.718/10

Growing faster than its price suggests

RITM4 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
57.6%10/10

Revenue surging 57.6% year-over-year

P/E RatioValuation
14.7x8/10

Attractively priced relative to earnings

Operating MarginProfitability
20.2%8/10

Strong operational efficiency at 20.2%

Areas to Watch

DX4 concerns · Avg: 2.5/10
P/E RatioValuation
38.6x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
-0.722/10

Distress zone — elevated risk

Profit MarginProfitability
-293.5%1/10

Currently unprofitable

RITM4 concerns · Avg: 2.0/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Free Cash FlowQuality
$-1.77B2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.402/10

Distress zone — elevated risk

Debt/EquityHealth
4.901/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : DX

The strongest argument for DX centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 234.8% demonstrates continued momentum. PEG of 0.71 suggests the stock is reasonably priced for its growth.

Bull Case : RITM

The strongest argument for RITM centers on Price/Book, Revenue Growth, P/E Ratio. Revenue growth of 57.6% demonstrates continued momentum.

Bear Case : DX

The primary concerns for DX are P/E Ratio, Piotroski F-Score, Altman Z-Score. Debt-to-equity of 7.93 is elevated, increasing financial risk.

Bear Case : RITM

The primary concerns for RITM are Piotroski F-Score, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.90 is elevated, increasing financial risk.

Key Dynamics to Monitor

DX profiles as a hypergrowth stock while RITM is a growth play — different risk/reward profiles.

RITM carries more volatility with a beta of 1.16 — expect wider price swings.

DX is growing revenue faster at 234.8% — sustainability is the question.

DX generates stronger free cash flow (81M), providing more financial flexibility.

Bottom Line

RITM scores higher overall (65/100 vs 55/100) and 57.6% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dynex Capital Inc

REAL ESTATE · REIT - MORTGAGE · USA

Dynex Capital, Inc., a mortgage real estate investment trust, invests in Mortgage-Backed Securities (MBS) on a leveraged basis in the United States. The company is headquartered in Glen Allen, Virginia.

Rithm Capital Corp.

REAL ESTATE · REIT - MORTGAGE · USA

Rhythm Capital Corp. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?